Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

17 Jun 2021 07:00

RNS Number : 1544C
Anpario PLC
17 June 2021
 

17 June 2021

 

Anpario plc("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Peter Lawrence, Chairman, will make the following comments:

 

"The Board would firstly like to thank all our staff and other stakeholders for their continued efforts in ensuring production and delivery of our products to our customers and subsidiaries around the world especially during this challenging period caused by the Covid 19 pandemic.

 

The Company has delivered good sales and improved profit performance with sales at a similar level to last year, which was a very strong comparative period as customers had increased stock levels at the onset of the pandemic. Most regions are performing to plan with China experiencing a very strong performance, benefiting from last year's ban on anti-biotic growth promoters (AGPs) in animal feed. South East Asia's performance is, however, weaker as countries imposed new lockdowns in response to increasing infection rates and, with less tourism which has reduced overall protein consumption.

 

Our Brexit contingency plans are working well, helping to reduce disruption and we now look forward to our efforts coming to fruition now supported by our European stockholding hub.

 

As with most industries, we are experiencing raw material price inflation and some disruption in our supply chains and global shipping operations. However, we are implementing price increases to help mitigate the increase in costs and our export and logistics team is managing to overcome the logistics issues. We expect these challenges to continue until the last quarter of this year.

 

It is worth noting that Anpario's unique formulation technology also benefits customers as we are able to offer solutions which are more cost effective than alternative competitor products.

 

We are encouraged by some recent business development successes including a large Brazilian poultry integrator using Orego-Stim® and growth in Latin America for our aquaculture products, which are currently being launched in specific countries across Asia. Our exciting growth opportunities and strong balance sheet, which is reflected in our strong cash position, gives me confidence that the Company will continue to develop and grow in the years ahead.

 

Finally, this is my last AGM as I retire from the Board today. I would therefore like to take the opportunity to thank all staff and shareholders for their loyalty and support of Anpario in helping to build a successful company which has delivered significant shareholder value. As I hand over the Chair to Kate Allum, I am confident that the board with its newer members, will successfully continue to steer the company through these unusual times to ensure to deliver value to our shareholders.

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 15 September 2021."

 

 

Enquiries:

Anpario plc

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

Karen Prior, Group Finance Director

+44 (0)1909 537 380

Peel Hunt LLP (NOMAD and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSERTIRLIL
Date   Source Headline
30th Jan 20207:00 amBUSTrading Statement
20th Jan 202010:05 amRNSHolding(s) in Company
17th Jan 20204:55 pmRNSBlock listing Interim Review
17th Jan 20209:40 amRNSHolding(s) in Company
13th Jan 202010:31 amRNSHolding(s) in Company
8th Jan 20203:39 pmRNSHolding(s) in Company
6th Jan 202011:04 amRNSHolding(s) in Company
18th Nov 20195:30 pmRNSHolding(s) in Company
5th Nov 20199:44 amRNSHolding(s) in Company
11th Sep 20197:00 amBUSHalf-year Report
14th Aug 201911:10 amRNSHolding(s) in Company
13th Aug 20196:08 pmRNSHolding(s) in Company
17th Jul 201910:41 amRNSBlock listing Interim Review
27th Jun 20194:23 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
21st Jun 20197:00 amRNSTotal Voting Rights
5th Jun 201910:47 amRNSDirector/PDMR Shareholding
4th Jun 20195:35 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:27 pmRNSHolding(s) in Company
17th Apr 20192:04 pmRNSHolding(s) in Company
2nd Apr 201910:33 amRNSTotal Voting Rights
8th Mar 201911:06 amRNSFinal Results
6th Mar 20197:00 amBUSFinal Results
5th Mar 20194:17 pmRNSTotal Voting Rights
29th Jan 20197:00 amRNSPre-Close Trading Statement
17th Jan 201912:17 pmRNSBlock listing Interim Review
6th Dec 20182:30 pmRNSHolding(s) in Company
6th Dec 20182:25 pmRNSHolding(s) in Company
2nd Oct 20183:51 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSHalf-year Report
31st Jul 20189:54 amRNSHolding(s) in Company
19th Jul 20183:30 pmRNSBlock listing Interim Review
28th Jun 20184:05 pmBUSResult of AGM
28th Jun 20187:00 amRNSAGM Statement
5th Jun 20183:58 pmRNSAnnual Report and Notice of AGM
4th Jun 20183:17 pmRNSTotal Voting Rights
4th May 201812:05 pmRNSTotal Voting Rights
9th Apr 20188:25 amRNSTotal Voting Rights
7th Mar 20187:00 amBUSFinal Results
5th Mar 20183:16 pmRNSHolding(s) in Company
5th Feb 20182:21 pmRNSTotal Voting Rights
29th Jan 20187:00 amRNSTrading Statement
19th Jan 20182:32 pmRNSBlock listing Six Monthly Return
22nd Nov 20174:53 pmRNSEmployee Share Plan and Directors' Dealing
20th Oct 20177:00 amRNSDirectorate Change
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding
19th Sep 20177:00 amBUSHalf-year Report
28th Jul 20179:46 amRNSBlock Listing Return
18th Jul 20174:58 pmRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.